Argos Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Buy
9,893
+192
+2% +$44.7K 0.67% 22
2026
Q1
$2.37M Buy
9,701
+80
+0.8% +$18.6K 0.68% 18
2025
Q4
$1.99M Buy
+9,621
New +$1.9M 0.53% 24

Other funds holding JNJ

Argos Wealth Advisors's JNJ Position: Q2 2026 in Review

Argos Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 2% in Q2 2026, buying an estimated $44.7K and bringing the position to 9,893 shares worth $2.51M. The position accounts for 0.67% of the portfolio, ranked #22.

Argos Wealth Advisors first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Argos Wealth Advisors held 9,893 shares of Johnson & Johnson worth $2.51M as of Q2 2026.
  • Argos Wealth Advisors bought 192 Johnson & Johnson shares in Q2 2026, an estimated $44.7K.
  • Johnson & Johnson made up 0.67% of Argos Wealth Advisors's portfolio in Q2 2026, its #22 holding.
  • Argos Wealth Advisors first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Argos Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.